Entopsis Inc. has developed a wide range of technologies in the life sciences industry, such as OpsisDx, PCRopsis, PlantOpsis, ZooOpsis, and Genurine. Each set of technologies addresses a distinct market niche, with distinct clients, key opinion leaders, business and scientific expectations, regulatory landscape, and interested investors. As such, Entopsis will create subsidiaries for each set of technologies to best address the particular business needs of each product line. The subsidiaries will hold exclusive rights to the underlying technology, while Entopsis will perform common operational tasks.
